✦ LIBER ✦

Goal Attainment Scaling as an Outcome Measure in Randomized Controlled Trials of Psychosocial Interventions in Autism

✍ Scribed by Lisa Ruble, John H. McGrew, Michael D. Toland

Book ID: 118800130
Publisher: Springer US
Year: 2012
Tongue: English
Weight: 277 KB
Volume: 42
Category: Article
ISSN: 1573-3432
DOI: 10.1007/s10803-012-1446-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Responsiveness of goal attainment scalin

Responsiveness of goal attainment scaling in a randomized controlled trial of comprehensive geriatric assessment

✍ Kenneth Rockwood; Susan Howlett; Karen Stadnyk; Daniel Carver; Colin Powell; Pau 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 270 KB

Screening, Intervention and Outcome in A

Screening, Intervention and Outcome in Autism and Other Developmental Disorders: The Role of Randomized Controlled Trials

✍ Fernell, Elisabeth; Wilson, Philip; Hadjikhani, Nouchine; Bourgeron, Thomas; Nev 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 145 KB

Changes in the “stages of change” as out

Changes in the “stages of change” as outcome measures of a smoking cessation intervention: A randomized controlled trial

✍ Anja Schumann; Ulrich John; Hans-Jürgen Rumpf; Ulfert Hapke; Christian Meyer 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 252 KB

Measuring Outcomes on an Inpatient Geria

Measuring Outcomes on an Inpatient Geriatric Evaluation and Management Unit: The Effectiveness of Goal Attainment Scaling in Patients with Dementia

✍ Gionet, Sherry; Jarrett, Pamela; Sutherland, Donald; McCloskey, Rose; Stewart, C 📂 Article 📅 2013 🏛 American Psychiatric Publishing Inc 🌐 English ⚖ 45 KB

A randomized controlled trial of an earl

A randomized controlled trial of an early intervention program in low birth weight children: Outcome at 2 years

✍ Per Ivar Kaaresen; John A. Rønning; Jorunn Tunby; Solveig Marianne Nordhov; Stei 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 298 KB

Using quality-adjusted progression-free

Using quality-adjusted progression-free survival as an outcome measure to assess the benefits of cancer drugs in randomized-controlled trials: case of the BOLERO-2 trial

✍ Vakaramoko Diaby,Georges Adunlin,Askal Ayalew Ali… 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 189 KB